Funding

NIH Funding (since 1998)

  1. SBIR Phase I, “Immunoassays for metabolites of AA epoxygenases”, Completed.

  2. SBIR Phase I, “Mutagenicity/genotoxicity assays with endogenous PGHS-2”, Completed.

  3. NIH R15GM59595, Co-I."Role of cytochrome P450 in isoflavone metabolism", Completed.

  4. SBIR Phase I, “Microarrays of X. laevis genes: a tool for Mol. Toxicology”, Completed.

  5. SBIR Phase II, “Immunoassays for metabolites of AA epoxygenases”, Completed.

  6. SBIR Phase II, “Mutagenicity/genotoxicity assays with endogenous PGHS-2”, Completed.

  7. SBIR Phase II, “Targeted antibody microarrays: a tool for Toxicoproteomics”, Completed.

  8. SBIR Phase II, “Microarrays of X. laevis genes: a tool for Mol. Toxicology”, Completed.

  9. SBIR Phase I, “Fetal alcohol syndrome biomarkers by antibody microarray”, Completed.

10. SBIR Phase I, N43CN53306, “Antibody microarray for cancer detection” Completed.

11. STTR Phase I, R41CA105578, “A molecular signature of cell invasion in breast cancer”, Completed.

12. SBIR Phase II, “Targeted antibody microarrays: a tool for Toxicoproteomics”, Completed.

13. SBIR Phase I, “Diagnostic ELISA to measure prostate cancer biomarker in serum” Completed.

14. SBIR Phase II, “Diagnostic ELISA to measure prostate cancer biomarker in serum” Completed.

15. Supplementary fund for SBIR Phase II, Completed.

16. SBIR Phase I, “Novel HTS for gap junctional communication” Completed.

17. SBIR Phase I, "Site-specific antibodies for proteins in cancer" Completed.

18, SBIR Phase I, "Glycoproteins: Biomarkers for cancer and inflammatory diseases" Completed.

19. SBIR Phase II, "Site-specific antibodies for GlcNAcylated proteins in cancer" Active.

20. SBIR Phase I, "Circulating Nucleic Acid-Based Nano Technology in Cancer" Active.